Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 2/20 | 0.59 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CA4 | P22748 | 2/20 | 0.59 |
| ▸ | CA6 | P23280 | 2/20 | 0.59 |
| ▸ | CA7 | P43166 | 2/20 | 0.59 |
| ▸ | CA9 | Q16790 | 2/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | ERN1 | O75460 | 3/20 | 0.58 |
| ▸ | KDM5A | P29375 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10606250 | 0.85 | TYR (0.49) | MAPTPOLBGAAL3MBTL1KDM4E | |
| SCHEMBL2554378 | 0.85 | ERN1 (0.75) | KDM4EERN1ALDH1A1TRIM24TRIM33 | |
| SCHEMBL1100563 | 0.83 | ERN1 (0.73) | MAPTPOLBGAAL3MBTL1KDM4E | |
| SCHEMBL29955642 | 0.83 | ERN1 (0.73) | MAPTPOLBGAAL3MBTL1KDM4E | |
| SCHEMBL4918747 | 0.83 | ALDH1A1 (0.52) | MAPTPOLBGAAL3MBTL1KDM4E | |
| SCHEMBL29941258 | 0.83 | ALDH1A1 (0.52) | MAPTPOLBGAAL3MBTL1KDM4E | |
| SCHEMBL11585526 | 0.82 | TYR (0.52) | MAPTPOLBERN1NPC1RAB9A | |
| SCHEMBL20769195 | 0.82 | CA12 (0.57) | MAPTPOLBGAAL3MBTL1KDM4E | |
| SCHEMBL14629136 | 0.82 | ERN1 (0.59) | ERN1TYRTRIM24TRIM33 | |
| SCHEMBL28054876 | 0.81 | ATM (0.53) | MAPTPOLBL3MBTL1KDM4EPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120115188-A | Vanadium-based catalyst, preparation method thereof and application thereof in catalyzing oxidation of 5-hydroxymethylfurfural to prepare 2, 5-diformylfuran | 中国科学院大连化学物理研究所 | 2025-06-10 | — | — | CN | claimed |
| CN-116200027-B | Flame-retardant nylon and preparation method thereof | 浙大宁波理工学院 | 2024-11-01 | — | — | CN | claimed |
| CN-118652281-A | Salamo-containing tetravalent platinum complex and preparation method and application thereof | 巴音郭楞蒙古自治州人民医院 | 2024-09-17 | — | — | CN | claimed |
| CN-118652282-A | Salen-containing tetravalent platinum complex and preparation method and application thereof | 巴音郭楞蒙古自治州人民医院 | 2024-09-17 | — | — | CN | claimed |
| CN-116200027-A | Flame-retardant nylon and preparation method thereof | 浙大宁波理工学院 | 2023-06-02 | — | — | CN | claimed |
| CN-111812069-B | Method for rapidly detecting zinc ions in traditional Chinese medicine on site | 上海应用技术大学 | 2023-04-28 | — | — | CN | claimed |
| CN-113398836-B | Particle-stabilized high internal phase switching emulsions, methods of making, and methods of recovering particles | 西南石油大学 | 2023-04-07 | — | — | CN | claimed |
| CN-114425086-A | Preparation method of MOF-808@ CREKA @ HDBB nano tumor targeting vector | 哈尔滨理工大学 | 2022-05-03 | — | — | CN | claimed |
| CN-113816940-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-21 | — | — | CN | claimed |
| CN-113754634-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-07 | — | — | CN | claimed |
| CN-113398836-A | Particle-stable high internal phase switching emulsion, preparation method and particle recovery method | 西南石油大学 | 2021-09-17 | — | — | CN | claimed |
| CN-111812069-A | Method for rapidly detecting zinc ions in traditional Chinese medicine on site | 上海应用技术大学 | 2020-10-23 | — | — | CN | claimed |
| US-20260107968-A1 | END PLUG COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107971-A1 | AEROSOL GENERATING MATERIAL IN DISCRETE PORTIONS COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107972-A1 | AEROSOL GENERATING GEL MATERIAL COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107967-A1 | AEROSOL GENERATING MATERIAL COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| EP-1143951-A2 | ANTIMALARIAL AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000016763-A2 | ANTIMALARIAL AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2000-03-30 | — | — | WO | disclosed |
| US-5278154-A | New vanadium complexes | ADIR ET COMPAGNIE (FR) | 1994-01-11 | — | — | US | disclosed |
| US-5266565-A | Antidiabetic | ADIR ET COMPAGNIE (FR) | 1993-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260107971-A1 | AEROSOL GENERATING MATERIAL IN DISCRETE PORTIONS COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHRM3, CHRM1 | MAPT 2855/4885POLB 2856/4885GAA 3960/4885 |
| US-20260107968-A1 | END PLUG COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE | ALK, EXOSC4, EXOSC9 | MAPT 4540/4885POLB 898/4885GAA 4054/4885 |
| US-20260107967-A1 | AEROSOL GENERATING MATERIAL COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, EXOSC4, CHRM3 | MAPT 522/4885POLB 3233/4885GAA 3099/4885 |
| US-20260107972-A1 | AEROSOL GENERATING GEL MATERIAL COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | ACTN1, ARPC3, ARPC4 | MAPT 1658/4885POLB 2639/4885GAA 3924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.